Arrowstreet Capital Limited Partnership Has $362,000 Position in Nu Skin Enterprises, Inc. (NYSE:NUS)

Arrowstreet Capital Limited Partnership grew its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS) by 92.7% during the fourth quarter, Holdings Channel reports. The firm owned 52,480 shares of the company’s stock after acquiring an additional 25,243 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Nu Skin Enterprises were worth $362,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in NUS. JPMorgan Chase & Co. boosted its stake in Nu Skin Enterprises by 175.6% during the third quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company’s stock worth $1,710,000 after acquiring an additional 147,784 shares in the last quarter. AlphaQuest LLC boosted its position in shares of Nu Skin Enterprises by 197.8% during the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company’s stock worth $746,000 after purchasing an additional 71,864 shares in the last quarter. Barclays PLC grew its stake in shares of Nu Skin Enterprises by 363.8% in the 3rd quarter. Barclays PLC now owns 85,437 shares of the company’s stock valued at $629,000 after buying an additional 67,016 shares during the period. Rhumbline Advisers increased its position in Nu Skin Enterprises by 70.9% in the 4th quarter. Rhumbline Advisers now owns 138,477 shares of the company’s stock valued at $954,000 after buying an additional 57,443 shares in the last quarter. Finally, American Century Companies Inc. raised its stake in Nu Skin Enterprises by 12.0% during the 4th quarter. American Century Companies Inc. now owns 824,739 shares of the company’s stock worth $5,682,000 after buying an additional 88,181 shares during the period. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Price Performance

NUS stock opened at $6.23 on Monday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. The business has a 50-day simple moving average of $7.28 and a two-hundred day simple moving average of $7.02. The company has a market capitalization of $309.53 million, a P/E ratio of -2.11 and a beta of 1.10. Nu Skin Enterprises, Inc. has a 52-week low of $5.75 and a 52-week high of $14.00.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Thursday, February 13th. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.14. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The company had revenue of $445.55 million for the quarter, compared to analysts’ expectations of $441.10 million. Research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 5th. Investors of record on Monday, February 24th were given a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.86%. The ex-dividend date of this dividend was Monday, February 24th. Nu Skin Enterprises’s payout ratio is currently -8.14%.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Tuesday, April 8th. DA Davidson decreased their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, December 20th.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.